Checkpoint Therapeutics, Inc. (CKPT)

Checkpoint Therapeutics Revenue

Checkpoint Therapeutics had revenue of $47.00K in the twelve months ending September 30, 2024, down -72.51% year-over-year. In the year 2023, Checkpoint Therapeutics had annual revenue of $103.00K, down -46.35%.

• Revenue (ttm): $47.00K
• Revenue Growth: -72.51%
• P/S Ratio: n/a
• Revenue / Employee: $2,043
• Employees: 23
• Market Cap: 157.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	103.00K	-89.00K	-46.35%
Dec 31, 2022	192.00K	-76.00K	-28.36%
Dec 31, 2021	268.00K	-801.00K	-74.93%
Dec 31, 2020	1.07M	-639.00K	-37.41%
Dec 31, 2019	1.71M	-1.80M	-51.28%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.